NCT07330466

Brief Summary

The aim of the study is to evaluate treatment outcomes of Spinal Cord Stimulation. In the study each patient participates in four test sessions of 4-5 hours. Patients arrive for test days with their stimulation on. In each test session, baseline pain is first evaluated. Then, SCS is regulated (on/off) and patients evaluate their pain intensity immidiately and every 15 minutes during the test sessions. Patients are blinded to the treatment conditions during their participation in the study. At all times, patients can resume their usual treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
14mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Sep 2024Jul 2027

Study Start

First participant enrolled

September 1, 2024

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

September 19, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 9, 2026

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

January 9, 2026

Status Verified

September 1, 2025

Enrollment Period

2.8 years

First QC Date

September 19, 2025

Last Update Submit

January 4, 2026

Conditions

Keywords

Spinal Cord StimulationChronic pain

Outcome Measures

Primary Outcomes (1)

  • Patients' subjective pain intensity evaluated on a 0-10 Mechanical Visual Analogue Scale (M-VAS)

    From enrollment to completion of four test sessions scheduled with a minimum interval of one week between each session.

Study Arms (4)

Placebo condition

PLACEBO COMPARATOR

The patient is incorrectly told that stimulation is on

Device: Stimulation OFFDevice: Told ON

Total treatment

ACTIVE COMPARATOR

The patient is correctly told that stimulation is on

Device: Stimulation ONDevice: Told ON

Stimulation treatment

OTHER

The patient is incorrectly told that stimulation is off

Device: Stimulation ONDevice: Told OFF

Control condition

OTHER

The patient is correctly told that stimulation is off

Device: Stimulation OFFDevice: Told OFF

Interventions

Stimulator will be turned on

Stimulation treatmentTotal treatment

Stimulation is turned off

Control conditionPlacebo condition
Told ONDEVICE

Verbal suggestion that stimulation is on

Placebo conditionTotal treatment
Told OFFDEVICE

Verbal suggestion that stimulation is off

Control conditionStimulation treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients (\>18 years of age) with SCS implanted to treat chronic pain.
  • Patients who consent to participation and can cooperate in the study.
  • Use of continuous paresthesia-free SCS for minimum 6 months prior to participation in the study.
  • Patients not receiving other neuromodulation treatment.
  • Patients who have not undergone changes in their (pain relevant) medication during the last 30 days (pro necessitate medication allowed).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University Hospital

Aarhus N, 8200, Denmark

RECRUITING

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Christina Emborg, Postdoc

CONTACT

Lene Vase, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postdoc

Study Record Dates

First Submitted

September 19, 2025

First Posted

January 9, 2026

Study Start

September 1, 2024

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

January 9, 2026

Record last verified: 2025-09

Locations